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Abstract Cartilage is a tissue with limited repair capacity
and also sparse population of cells entrapped within a
dense extracellular matrix, therefore, delivery of the cells
to site of damaged cartilage can improve its healing
potential. Synthetic biomaterials such as poly (D,L-lactide-
co-glycolide) (PLGA) have been used as both preformed or
injectable scaffolds in tissue engineering in order to carry
and keep cells in the site of injury with minimal side
effects. The injectable biocompatible polymeric scaffolds
can reach to effected area via minimally invasive injection
without need to open the joint, less painful approach and
also having possibility to fill complicated shape defects. In
this study, it was hypothesized that PLGA solved in n-
methyl pyrrolidine (NMP) may act as a proper carrier for
cell delivery to the site of the damage and also supports
their growth. The results of in vitro assays including both
live/dead (AO/PI) and MTT showed the majority of the
cells were remained alive between 3 up to 21 days,
respectively. The amount of resealed GAG from the mes-
enchymal stem cells (MSCs) which were in contact with
both PLGA and alginate constructs (used as control) indi-
cated that for day 7 MSCs in contact with alginate secreted
more GAG (3.45 ± 0.453 lg/mL for alginate and
2.36 ± 0.422 lg/mL for PLGA matrices), but at longer
times (21 days) cells in contact with PLGA elicited more
GAG (6.26 ± 0.968 lg/mL for alginate and 8.47 ±
0.871 lg/mL for the PLGA matrices). Sol–gel systems
comprising PLGA, NMP, and cells as well as alginate/cells
were subcutaneously injected into four nude mice (each
mouse had three injection sites). PLGA/NMP was solidify
immediately and formed an interconnecting 3-D porous
structure that allowed body fluid to penetrate through them.
In vivo evaluation showed that PLGA/NMP scaffolds
could support injected cells as a fibrocartilage tissue was
formed after 6 months of injection. We found that PLGA/
NMP system might be a proper minimally invasive thera-
peutics option for cartilage repair.
Keywords Cartilage tissue engineering  Injectable
scaffolds  poly (D,L-lactide-co-glycolide)  Mesenchymal
stem cells (MSCs)
Introduction
There are no nerves or blood vessels in cartilage tissue, and
problematic point is that when it damages due to any reason
such as disease or trauma, it does not heal spontaneously and
also leads to sever pain and disability (Capito et al. 2005;
Kreuz et al. 2013). Although numerous treatment protocols
are currently employed clinically, few approaches, if any,
exist which are capable of consistently restoring long-term
function to damaged articular cartilage and rest are failed of
completely restore cartilage structure and function because
of invasiveness of the methods and complex properties of
the cartilage tissue (Vinatier and Mrugala 2009).
Since, cartilage is a tissue, with sparse population of
cells entrapped within a dense extracellular matrix (ECM),
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therefore, delivery of cells to site of damaged cartilage
using a carrier may improve its healing potential (Puppi
and Chiellini 2010). Therefore, tissue engineering approa-
ches using scaffold architecture for delivery of cells in an
organized manner to the site of cartilage defects, offer great
promise as repair strategies (Lara-Curzio and Readey
2004). In overall, the tissue engineering scaffolds can be
divided into two main types including preformed and
injectable (Zilberman 2011; Parka et al. 2013). From
clinical perspective, the use of injectable scaffolding
materials for in vivo tissue regeneration is attractive
because it allows cell implantation through minimally
invasive and routine surgical procedures (Bakhshi and
Vasheghani-Farahani 2006; Francisco et al. 2013). In fact,
this approach is less invasive and less painful compared to
opening the joint and implants combination of cells and
scaffold in it. Another advantage of using injectable scaf-
folds is that they can easily fill defects of various sizes and
shapes without any need to fabricate scaffolds of compli-
cated shapes (Hu et al. 2008). Injectable, in situ forming
materials have been extensively used as career in drug
delivery systems (DDS). As it was mentioned in a review
published by Mikos et al., due to the advantages of
injectable materials for both drug delivery systems and
tissue engineering, the experience transfer from injectable
carrier in field of DDS in order to reach appropriate in situ
forming scaffolds is warranted (Jia and Kiick 2009). The
application of injectable implant system comprises a water-
insoluble biodegradable polymer, poly (D,L-lactide-co-gly-
colide) (PLGA) a copolymer with a 50:50 molar ratio
containing carboxyl end groups, dissolved in a water-mis-
cible and physiologically compatible organic solvent, N-
methyl-2-pyrrolidone (NMP) already has been investigated
for DDS applications (Bakhshi and Vasheghani-Farahani
2006; Tahereh Darestani Farahani et al. 2005; Astaneh
et al. 2009). Considering the necessary characteristics for
tissue engineering scaffolds and how current injectable
systems which were used as drug carrier could be modified
to facilitate their use as injectable scaffolds was the moti-
vation of current study. In fact, in this research, the
potential of PLGA/NMP injectable system to act as cell
delivery carrier was investigated. Upon injection into an
aqueous environment, the organic solvent diffuses into the
surrounding environment while water diffuses into the
polymer matrix. Then, the polymer precipitates in contact
with water and results in a solid polymeric implant and
formation of an interconnecting 3-D porous structure that
allowed body fluid to penetrate through it.
The rationale behind of this work was a hypothesis that
might be simultaneous injection of cells and scaffold create
a solidified microenvironment to motivate cell growth and
proliferation. To compare the biological function of PLGA/
NMP, alginate, a biocompatible hydrogel which has been
shown to be effective cell delivery carrier (Marijnissen
et al. 2002; Sah et al. 2003; Tig˘li and Gu¨mu¨s¸dereliog˘lu
2009), was also used.
Materials and methods
Scaffold preparation
Sample 1: based on PLGA
Poly (D,L-lactide-co-glycolide) (PLGA) 50:50 (RG 505,
inherent viscosity = 0.54 dL/g in chloroform at 25 C,
Mw = 24,000) to a biocompatible solvent, N-methyl-2-
pyrrolidone (NMP, Merck, Germany) in solution
between 30 % of PLGA and 70 % of NMP, both com-
ponents are FDA approved, was prepared. It was seen
that 70:30 w/w PLGA: NMP solution had enough low
viscosity for easy injection. The PLGA solutions were
gamma irradiated (dose of 25 kGy). Then, injected into
a cylindrical mould with height twice than width that
was filled with phosphate-buffered saline (PBS),
exchanging the NMP and water the porous scaffold was
prepared.
Sample 2: based on alginate
Alginate solution of 1.2 % was prepared by adding alginic
acid (Fluka, Biochemica) to 0.9 % NaCl while stirring.
Afterward the solution of alginic acid in saline was injected
into a tube containing calcium chloride solution through a
syringe. The alginate droplets crosslinked and resulted in
alginate beads.
Scanning electron micrograph of scaffold
Surfaces and cross-sections microstructure of the injected
PLGA/NMP system into PBS solution were studied using a
scanning electron microscope (SEM), Vega-II XMU (Te-
scan USA Inc). For this purpose, the injected substrate
were remained in PBS for duration of 48 h and broken in
liquid nitrogen after freezing (Astaneh et al. 2009).
Mechanical property of the scaffolds
First, the hydrogels comprising PLGA/NMP without cells
were injected into a vital containing aqueous solution to be
solidified as a scaffold. Thereafter, the compression mod-
ulus of the scaffolds was evaluated using ASTM standard
procedure (ASTM 1996). These tests were performed uti-
lizing a dynamic servo hydraulic testing machine (HCT
25-400, Zwick/Roell, Germany). Data were analyzed using
ToolKit98 (Zwick/Roell, Germany) software. Three
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cylindrical samples with height twice than of their width
were prepared and compressed to their half height at a
speed of 0.5 mm/min. At this point the maximum load was
measured and data expressed.
In vitro assays
Extraction of the samples
In order to evaluate the effect of PLGA-based and alginate-
based scaffolds on the cell growth and proliferation, an
extraction process was done according to the ISO 10993-5.
The biopsy of each scaffold with the weigh within a range
of 0.1–0.2 g was taken and 1 mL of culture medium was
added to each ones. After 7 and 21 days these mediums
were taken out to use in cell proliferation assay. A specified
amount of culture medium was kept in the same condition
as a negative control.
Cell proliferation assay
Both human bone marrow-derived mesenchymal stem cells
(MSCs) and mouse chondrocyte cells which were used in
this study were kindly provided by Royan Institute (Teh-
ran, Iran). Proliferation rate of MSCs on the samples were
measured using MTT assay. Briefly, at the first day MSCs
were plated into a 96-well microtiter plate at 1 9 104 cells/
well. After 24 h, the culture medium of each well was
removed and replaced with 90 lL extract plus 10 lL FBS.
In the next 24 h, the medium eliminated and 100 lL of a
0.5 mg/mL solution of MTT (Sigma, USA) was added to
each well followed by incubation for 5 h at 37 C. The
purple formazan crystals (formed in the mitochondria of
the cells) were detected and later dissolved by addition of
100 lL isopropanol (Sigma, USA) per well. The plates
were then incubated at 37 C for 15 min prior to absor-
bance measurements. The optical density (OD) was
recorded on a multi well microplate reader (ICN, Swit-
zerland) at 545 nm and normalized to the control OD.
Live/dead assay
About 1 9 104 MSC cells were mixed with 1 mL of
alginate solution or poured onto PLGA scaffolds, then
placed into a 12-well cell culture plate, and incubated at
37 C for 3 days (n = 3). Cell viability in the alginate
hydrogel was assessed by using acridine orange-propidium
iodide (AO/PI) staining. Briefly, the stock solution (AO:
670 mmol/L, PI: 750 mmol/L) was prepared with Dul-
beccos solution and kept in the dark at 4 C. Just before
use, 0.01 mL AO and 1.0 mL PI were mixed, diluted by 10
times with Dulbeccos solution, and then passed through a
0.22-lm filter membrane. The scaffolds containing MSC
were incubated with the AO/PI mixture and observed under
a fluorescence microscope later to evaluate the amount of
live cells which stain in green (AO) and also dead cells
which will be colored in red (PI) (Hao and Wen 2010).
Proteoglycan content analysis
GAG content was determined using DMMB assay for the
MSCs seeded on each PLGA and alginate scaffolds for
duration of 7 and 21 days. Both samples were papain
digested and analyzed for glycosaminoglycan (GAG) con-
tent using the DMMB-dye binding assay. Briefly, 50 ll of
papain digested sample was incubated with 2 mL of
DMMB-dye, and the reaction was observed using an ELISA
plate reader at 545 nm, with chondroitin sulfate (shark car-
tilage extract, Sigma) used as a standard (Park et al. 2007).
In vivo assay
A double syringe comprising the two separate cylinders and
25-gauge needle was used in order to deliver adequate amount
of cells and injectable scaffolds into subcutaneous space of
four nude mice simultaneously as presented in Fig. 1. In fact,
one syringe contained either 70:30 v/v of PLGA: NMP
solution or alginate/CaSO4 mixture (which had previously
been sterilized by a 0.22 lm filter) and another one was
contained the mouse chondrocyte cell with the density of 1
million cells/mL. The amount of cells and polymer solutions
in each injection site are presented at Table 1. Mice were
sacrificed at 2 and 24 weeks by anesthesia overdose and
samples were harvested from cell alone and cell-polymer
samples. Cartilage structures, if any, were excised, fixed in
10 % buffered formalin for pathological investigation. Since
a nude mouse has tiny body then a subcutaneous space of it
also has low capacity. Therefore, for cover three injection
sites for any mouse, each injection contained 0.3 mL com-
bination of cells and polymer solution.
Histology
Samples from each injection site and time point were
rinsed in 2.5 mL PBS for 1 h and then fixed in 10 %
Fig. 1 Three injection sites for each nude mouse, site 1 PLGA/NMP
and cells, site 2 alginate gel and cells, and site 3 control (i.e., only
cells)
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neutral-buffered formalin (Sigma-Aldrich). After fixation,
these samples were dehydrated by immersion in a series of
ethanol solutions (70, 80, 85, 90, 95, and 100 %) and
xylene solutions in ethanol (50 and 100 %). Specimens
were then embedded in paraffin and cross-sectioned to a
thickness of 20 lm using a microtome (Microm, Walldorf,
Germany). Sections from all groups were simultaneously
stained with hematoxylin and eosin (Park et al. 2005).
After fixation with 10 % phosphate-buffered formalin for
at least 24 h, specimens were embedded within paraffin
and sectioned. Using standard histochemical techniques,
serial sections were stained with hematoxylin and eosin
stains (Chang et al. 2001).
Statistical analysis
Experiments were run in triplicate for each sample. All
data are expressed as mean ± standard deviation (SD).
Utilizing one-way analysis of variance (ANOVA) SPSS
16.0 software which followed by Tukeys HSD post hoc
test, statistical analysis between groups was performed.
P values of less than 0.05 and less than 0.001 were con-




Figure 2 shows the surface micrographs of three solidified
PLGA/NMP scaffolds 3 days after their injection into an
aqueous media with different magnifications (1259, 250
and 500). It is known that the pore size of the scaffold plays
an important role in cell binding, migration, and ingrowth.
Although nutrient materials, gases, and metabolic waste
can be transported more easily via interconnected large
pores in the scaffold, large pores can lead to low cell
attachment and intracellular signaling. In contrast, small
pores can have the opposite effect, in which cell attachment
is promoted, but there is poor nutrient and gas delivery
(Annabi et al. 2011). The broad range for pore sizes with
good distribution of small and big pore diameters can be
seen in SEM pictures of Fig. 2. The average diameter of
large pores was nearly about 129.44 ± 23 lm. This
anisotropic distribution of pores is favored for cartilage
tissue engineering as mentioned in the literature (Annabi
et al. 2011).
Fig. 2 Morphological observations by SEM, PLGA scaffold a (9125), b (9250) and c (9500)
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Mechanical property of the scaffolds
The scaffolds which are designed for load-bearing appli-
cations such as musculoskeletal tissues should provide
sufficient mechanical support to match the mechanical
property of the host tissue to bear the in vivo stresses and
loadings. In the other words, mechanical compatibility or
similarity (matching) between the scaffold and tissue plays
a crucial role in homeostasis, remodeling, and repair of
load-bearing tissues, such as bone and cartilage (Duncan
and Turner 1995; Carter et al. 1988; Jin et al. 2003). Ide-
ally, the most desirable mechanical properties for a scaf-
fold are those closest to real tissue. The compression tests
carried out in this project were used to evaluate the
mechanical properties of PLGA injectable scaffold. As it is
reported in the literature (Southgate et al. 2009), natural
human cartilage has compression modulus in range of
0.5–1.5 (MPa) (Yuehuei and Kylie Martin 2010). The
related data for PLGA scaffold without cells shows com-
pression modulus of 0.5 ± 0.06 MPa which is near to
minimum amount of aforementioned range. It seems likely
that ECM secretion via chondrocyte cells could also
improve the scaffolds mechanical properties. However,
these data are not available now.
In vitro assays
MTT assay
After 3 days of cell culture, the cell proliferation was
determined by the MTT method. The MTT is a reliable
assay method for measuring cell viability in different sub-
strates, especially in rigid and porous scaffolds. This assay
determines viable cell numbers and is based on the mito-
chondrial conversion of the tetrazolium salt, 3(4,
5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazoliumbromide
(MTT) (Karbasi et al.2005; Park et al. 2005). The MTT
assay was performed at 7 and 21 days to determine cell
growth within both PLGA and alginate scaffolds and results
are presented in Fig. 3. Cell proliferation remained steady
in both samples after 7 days, while a considerable increase
in cell amount could be seen at day 21 of alginate sample.
This significant increase at day 21 can be attributed to the
difference in nature of PLGA and alginate scaffold. It has
been mentioned in the literature that synthetic material such
as PLGA have less cell adhesion and growth in comparison
with naturally derived polymers such as alginate (Chang
et al. 2001). Also, it is reported that PLGA due to enzymatic
degradation converts to lactide and glycolide acids which
led to decreasing of physiologic pH surrounding tissues and
subsequently prevent cell growth (Sung et al. 2004).
Live/dead assay
To visualize the cell viability in the scaffolds, living and
dead cells in PLGA and alginate matrix were fluorescently
stained using AO/PI staining. As shown in Fig. 4, the MSC
cells remained viable in both PLGA and alginate matrix
after being cultured for 3 day in vitro to some extent.
Comparison the number of living cells (stained green) and
dead cells (stained red) in PLGA and alginate substrate is
shown in Fig. 4a, b, respectively, it looks like that nearly
no dead cells is seen in alginate matrix meanwhile the
number of red points is more in Fig. 4b. This result is
consistent with the MTT assay outcome which shows better
cell viability for alginate rather than PLGA in close system
of in vitro (Hao and Wen 2010; Ibusuki et al. 2003).
Table 1 Content of cells and

















Total volume of injection
(cells ? polymer
solution) (mL)
1 0.15 0.6 0.15 – 0.3
2 0.15 0.6 – 0.15 0.3
3 0.3 0.6 – – 0.3
Fig. 3 The viability of MSCs after exposed to 7 and 21 days (n = 3,
mean ± SD), values of P [ 0.05 were considered no significant (*)
and P \ 0.05 were considered significant (**). (C is stand for
crosslinked samples)
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Proteoglycan content analysis
The amount of resealed GAG from the cells which were in
contact with PLGA and alginate constructs for duration of
7 and 21 days is shown in Fig. 5. The total GAG at day 7
was 3.45 ± 0.453 lg/mL for alginate and 2.36 ±
0.422 lg/mL for the PLGA matrixes, and the total GAG at
day 21 was increased to 6.26 ± 0.968 lg/mL for alginate
and 8.47 ± 0.871 lg/mL for the PLGA matrices. At day 7,
alginate construct encapsulating MSC cells possesses sig-
nificantly higher GAG content in comparison with PLGA.
The rationale behind this variation might be due to alginate
nature or hydrophobicity of PLGA which limited cell
adhesion on PLGA as shown the same result in MTT assay.
For both scaffolds, an increase in GAG production was
observed with longer culture time period since 7–21 days.
At last, PLGA career showed more cell supporting and
higher GAG content in comparison with alginate scaffolds
(Park et al. 2005). This observation for day 21 is in
contradiction with the results for day 7. This contradiction
might be due to the weakness in mechanical properties of
alginate which make it very loose to support cell activity
and ECM secretion meanwhile PLGA matrix (with higher
mechanical properties) can be better support for cells in the
longer times (Dai et al. 2010; Mercier et al. 2004).
In vivo assay
Histological analysis by H&E staining of combination of
cells and scaffolds retrieved at 2 and 24 weeks is shown at
Figs. 6 and 7, respectively. The in vivo results after
2 weeks showed that in site 1 (PLGA/NMP) and 2 (algi-
nate), there were chondrocyte cells which remained alive
but no tissue samples could be harvested from cell-injected
site without scaffold (site 3) because there was no tissue
formation over there as a result of cells migration, apop-
tosis, or reabsorption (Shafiee and Soleimani 2011). Our
investigations after 24 weeks showed that chondrocyte
accompanied by PLGA polymer regenerated more mature
and well-formed cartilage, as evidenced by bigger chon-
drocyte core size in comparison with alginate (Mercier
et al. 2005). In this study, a natural polymer was used as
control because it is known that naturally occurring bio-
polymers such as alginate due to their biodegradability, low
toxicity, and low disposal costs are proper choice to act as
tissue engineering scaffold. Furthermore, alginate is espe-
cially an appropriate biomaterial for the cartilage tissue as
it can closely mimics the natural environment or cartilage
ECM (Fan et al. 2006). H&E staining results after
24 weeks of in vivo implantation showed comparable
results with outcome of proteoglycan production amount
in vitro (mentioned in Sect. ‘‘Proteoglycan content ana-
lysis’’). Actually, the size of cell’s core in site 1 (PLGA)
was bigger than site 2 (alginate), that might be due to better
support to cells behalf stiff PLGA matrix rather than loose
alginate carrier which may causes the cell shrinkage and
Fig. 4 The AO/PI staining of a alginate, b PLGA, MSCs remained [90 % viable in both scaffold cultured after 7 day, AO green, PI red
Fig. 5 Total GAG contents in scaffolds after 7 and 21 days. (n = 3,
mean ± SD), values of P \ 0.05 were considered significant (**) and
P \ 0.001 were considered very significant (***)
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apoptosis. The fact that obtained in vitro and in vivo results
of PLGA scaffolds is comparable to those of alginate
makes a support for using this synthetic injectable structure
for repairing damaged cartilage. Histopathological inves-
tigation showed that there is no significant difference
between the chondrocyte core size which was accompanied
by either PLGA or alginate.
Conclusion
In many clinical situations involving replacement of hard
or soft tissue, the aims of minimizing the need for invasive
surgery, avoiding the medical complications associated
with harvested tissue, and overcoming the limitations of
preformed scaffolds have assumed primary importance.
Therefore, the use of noninvasive, injectable biomaterials
with the capacity to fill irregular defects is so attractive and
responds to these concerns. When properly designed, an
injectable scaffold can provide a structure that encapsulates
a homogeneous distribution of cells and bioactive mole-
cules that stimulate the regeneration of bone and cartilage
in a biomimetic fashion (Hu et al. 2008; Mercier et al.
2005; Migliaresi et al. 2007). In this study, the potential of
a biocompatible system including PLGA and NMP which
both could gained FDA approval for human use was
Fig. 6 Light micrographs of a histological slide after 2 weeks of injection, a site 2 (cell ? alginate) and b site 1 (cell ? PLGA), scale bar
250 lm
Fig. 7 Light micrographs of a
histological slide after 24 weeks
of injection, a, b site 2
(cell ? alginate) and c, d site 1
(cell ? PLGA), scale bar
250 lm
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assayed in order to act as cartilage scaffold, and the in vitro
and in vivo results showed promising results. The MTT
results showed that although MSCs cells had better growth
and viability in contact with alginate gel rather than PLGA
scaffolds, but the amount of produced extracellular matri-
ces (e.g., glycosaminoglycan) of them was better in contact
with PLGA which had higher mechanical support for the
cells. The positive effect of mechanical stimulation on
GAG expression during the differentiation of MSCs into
chondrocytes was observed in our previous study too
(Karkhaneh et al. 2014). The in vivo results implied that as
the PLGA scaffold degrades, the porous spaces could be
replaced with regenerating fibro-cartilage tissue. Direct
injection of chondrocyte suspensions without any scaffold
was conducted as a control experiment, but the localization
of transplanted chondrocytes was difficult to control, and
new cartilage tissue formation was not observed. We found
that PLGA/NMP system might be a proper minimally
invasive therapeutics option for cartilage regeneration.
Open Access This article is distributed under the terms of the
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